Latest market price
0.80
+0.02+2.30%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -0.20 | Insider Own | 24.60% | Shs Outstand | 327.41M | Perf Week | 21.05% |
| Market Cap | 254.75M | Forward P/E | — | EPS next Y | -0.14 | Insider Trans | -0.03% | Shs Float | 299.39M | Perf Month | -12.05% |
| Enterprise Value | 98.75M | PEG | — | EPS next Q | -0.05 | Short Float | 14.33% | Perf Quarter | 39.47% | ||
| Income | -68.00M | P/S | 10.61 | EPS this Y | — | Short Ratio | 2.06 | Perf Half Y | -24.46% | ||
| Sales | 24.00M | P/B | 1.36 | EPS next Y | — | ROA | -28.77% | Short Interest | 42.90M | Perf YTD | -56.77% |
| Book/sh | 0.57 | P/C | 1.56 | EPS next 5Y | — | ROE | -32.62% | 52W High | 2.62 -69.62% | Perf Year | -63.47% |
| Cash/sh | 0.50 | P/FCF | — | EPS past 3/5Y | — | ROIC | -35.07% | 52W Low | 0.49 62.15% | Perf 3Y | -60.50% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | — | Gross Margin | 27.75% | Volatility | 16.85% 14.27% | Perf 5Y | -92.23% |
| Dividend TTM | — | EV/Sales | 4.11 | EPS Y/Y TTM | — | Oper. Margin | -312.83% | ATR (14) | 0.11 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 6.22 | Sales Y/Y TTM | 100.00% | Profit Margin | -289.64% | RSI (14) | 52.63 | Recom | 3.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 6.52 | EPS Q/Q | 42.86% | SMA20 | 0.35% | Beta | 0.83 | Target Price | 1.10 |
| Payout | 0.00% | Debt/Eq | 0.04 | Sales Q/Q | 25.00% | SMA50 | 18.98% | Rel Volume | 0.89 | Prev Close | 0.78 |
| Employees | 215 | LT Debt/Eq | 0.03 | Earnings | Nov 12 | SMA200 | -24.35% | Avg Volume | 21.32M | Price | 0.80 |
| IPO Date | Mar 01, 2021 | Option/Short | No / No | EPS/Sales Surpr. | -9.98% -8.93% | Net Debt/EBITDA | — | Volume | 18,884,114 | Change | 2.30% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-12-26 | Reiterated | Deutsche Bank | Hold | $1.40 → $1.10 |
| Apr-27-26 | Reiterated | Deutsche Bank | Hold | $1.30 → $1.40 |
| Nov-06-25 | Reiterated | Cantor Fitzgerald | Overweight | $4.00 |
| Sep-09-24 | Resumed | Deutsche Bank | Hold | $1.50 |
| Jun-08-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
Latest News· Times ET
Oct-30-26
Oct-30-2601:35PM
Oct-27-26
03:50AM
SES and CANAL+ Strengthen Strategic Partnership Through 2040businesswire.com
Oct-22-26
Oct-20-26
Oct-20-2609:07AM
Oct-19-26
Oct-19-2607:00AM
Oct-16-26
Oct-05-26
Oct-01-26
Oct-01-2602:00PM
Sep-30-26
Sep-29-26
Sep-28-26
Sep-28-2608:00AM
07:21AM
SES Launches Cash Tender Offerbusinesswire.com
Sep-24-26
02:50AM
SES Advances Satellite Manufacturing Facility in Luxembourgbusinesswire.com
Company
SES AI Corporation develops and produces AI enhanced lithium metal and lithium-ion rechargeable battery technologies for electric vehicles, urban air mobility, drones, robotics, battery energy storage systems, and other applications. It manufactures and sells residential and commercial ESS systems, li-ion, li metal battery cells and battery materials, such as electrolytes for automotive original equipment manufacturers and others. The company operates in the United States and the Asia Pacific regions. SES AI Corporation was founded in 2012 and is headquartered in Woburn, Massachusetts.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 6/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 24 | 21 | 2 | 0 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 16 | 10 | 1 | 0 | — | — | — | — | — | |
| Gross Profit | 7 | 11 | 1 | 0 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 30 | 27 | 38 | 47 | — | — | — | — | — | |
| Research and Development | 50 | 67 | 72 | 31 | — | — | — | — | — | |
| Other Operating Expense | -1 | 0 | 1 | 0 | — | — | — | — | — | |
| Operating Income | -74 | -83 | -109 | -78 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 5 | 10 | 9 | 24 | — | — | — | — | — | |
| Net Income Before Taxes | -68 | -73 | -100 | -54 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | -1 | — | — | — | — | — | |
| Consolidated Net Income | -68 | -73 | -100 | -53 | — | — | — | — | — | |
| Net Income From Continuing Operations | -68 | -73 | -100 | -53 | — | — | — | — | — | |
| Net Income | -68 | -73 | -100 | -53 | — | — | — | — | — | |
| EPS (Recurring) | -0.20 | -0.22 | -0.31 | -0.17 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.20 | -0.22 | -0.31 | -0.17 | — | — | — | — | — | |
| EPS (Diluted) | -0.20 | -0.22 | -0.31 | -0.17 | — | — | — | — | — | |
| EBITDA | -57 | -63 | -92 | -49 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 11.14 | 28.37 | 352.59 | — | — | — | — | — | — | |
| Gross Margin | 29.17 | 52.38 | 50.00 | — | — | — | — | — | — | |
| Operating Margin | -308.33 | -395.24 | -5,450.00 | — | — | — | — | — | — | |
| Net Margin | -283.33 | -347.62 | -5,000.00 | — | — | — | — | — | — | |
| Shares Outstanding | 336 | 331 | 322 | 315 | — | — | — | — | — | |
| Market Capitalization | 267 | 596 | 705 | 576 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Pilkington Kyle | CHIEF LEGAL OFFICER | May 22 '26 | Sale | 1.20 | 25,000 | 30,007 | 1,023,548 | May 27 |
| Pilkington Kyle | CHIEF LEGAL OFFICER | Mar 09 '26 | Sale | 1.20 | 25,000 | 30,000 | 780,203 | Mar 11 |
| Gan Hong | CHIEF SCIENCE OFFICER | Jan 23 '26 | Option Exercise | 0.16 | 100,000 | 16,000 | 1,353,286 | Jan 23 |
| Gan Hong | CHIEF SCIENCE OFFICER | Jan 23 '26 | Sale | 2.50 | 100,000 | 250,320 | 1,253,286 | Jan 23 |
| Gan Hong | CHIEF SCIENCE OFFICER | Jan 22 '26 | Sale | 2.50 | 150,000 | 374,385 | 1,253,286 | Jan 23 |
| Gan Hong | CHIEF SCIENCE OFFICER | Jan 22 '26 | Option Exercise | 0.16 | 150,000 | 24,000 | 1,403,286 | Jan 23 |
| Gan Hong | CHIEF SCIENCE OFFICER | Dec 15 '25 | Sale | 1.98 | 100,000 | 197,890 | 1,253,286 | Dec 16 |
| Gan Hong | CHIEF SCIENCE OFFICER | Dec 15 '25 | Option Exercise | 0.15 | 100,000 | 15,068 | 1,353,286 | Dec 16 |
| Gan Hong | CHIEF SCIENCE OFFICER | Nov 17 '25 | Option Exercise | 0.15 | 150,000 | 22,500 | 1,403,286 | Nov 18 |
| Gan Hong | CHIEF SCIENCE OFFICER | Nov 17 '25 | Sale | 1.90 | 150,000 | 285,225 | 1,253,286 | Nov 18 |
| Pilkington Kyle | CHIEF LEGAL OFFICER | Feb 10 '25 | Sale | 1.17 | 44,051 | 51,597 | 496,580 | Feb 11 |
| Li Gang | CHIEF MANUFACTURING OFFICER | Feb 10 '25 | Sale | 1.17 | 15,909 | 18,634 | 224,473 | Feb 11 |
| Gan Hong | CHIEF SCIENCE OFFICER | Feb 10 '25 | Sale | 1.17 | 51,600 | 60,439 | 773,906 | Feb 11 |
| Nealis Jing | CHIEF FINANCIAL OFFICER | Feb 10 '25 | Sale | 1.17 | 80,992 | 94,866 | 1,841,637 | Feb 11 |
| Hu Qichao | CEO & CHAIRMAN | Feb 10 '25 | Sale | 1.17 | 194,459 | 227,770 | 2,781,769 | Feb 11 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.